Transformation Growth Factor (TGF-beta) and Kidney Transplantation
Authors:
I. Matl; O. Viklický
Authors‘ workplace:
Klinika nefrologie Transplantcentra IKEM, Praha
Published in:
Čas. Lék. čes. 2002; : 601-605
Category:
Overview
Transformation growth factor (TGF-beta) is a cytokine, which takes part in many clinical conditions linked todifferent chronic disease states. Its production is regulated by genes and polymorphism of TGF-beta gene individuallypredetermines levels of its production. TGF-beta is produced by a number of normal, predominately haemopoieticand tissue cells. Moreover, it controls cell proliferation and differentiation, and namely it stimulates fibrogenesis.Profibrogenic efficacy plays a physiological role in wound healing and it is implicated in a spectrum of disease states,such as diabetic nephropathy, chronic glomerulonepthritis, lung fibrosis, or postirradiation fibrosis. In kidneytransplant recipients, TGF-beta has been suggested to be involved in the chronic rejection pathogenesis by enhancingfibrogenesis.
Key words:
cytokines, extracellular matrix, fibrogenesis, glomerulonephritis, chronic rejection, cyclosporin,losartan.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Transformation Growth Factor (TGF-beta) and Kidney Transplantation
- Benign Stenoses of the Large Respiratory Pathways
- Some Less Known Risk Factors of Atherogenesis – Homocysteine, Lipoprotein (a) andC-reactive Protein
- Cardiology Update 2001A review of the most important topics published